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osteoarthritis and 5348 controls. 186 of the patients were categorized to
a group of ‘probable osteoarthritis’ and 216 to a group of ‘deﬁnite
osteoarthritis’ using standard criteria based on medical history, symp-
tom history and physical status. The genotypes were determined by
PCR-based methods, iPlex/Sequenom MALTI-TOF mass array analyzer
and OpenArray. Background data were collected by a questionnaire.
Associations between the SNPs and knee OA were studied by SAS and
IBM SPSS statistical package Version 20.
Results: The nucleotide substitution A>T in FTO gene (rs9939609)
was found to correlate with osteoarthritis. Surprisingly this correla-
tion was statistically signiﬁcant only in the ‘probable osteoarthritis’-
group (OR ¼ 1,566, 95% CI: 1,040-2,360; p ¼ 0,032) and not in the
‘deﬁnite osteoarthritis’ group (OR ¼ 1,063, 95% CI: 0,713-1,584; p ¼
0,765). The result remained signiﬁcant in the ‘probable osteoarthritis’
group when adjusted with age and gender (OR ¼ 1,608, 95% CI:
1,047-2,470; p ¼ 0,030). When adjusted with BMI, the signiﬁcance
became non-signiﬁcant (OR ¼ 1,526, 95% CI: 0,990-2,344; p ¼
0,056).
Conclusions: Our results suggest that FTO gene has a role in knee OA.
However, it seems that the interaction is at least partly explained by
BMI.Change in semi-quantitative feature at 24 months and prediction of case control status OR (95% CI) p
Semi-quantitative feature Case (JSL and pain) (n ¼ 194)
vs. all controls (n ¼ 406)
Super Control
(n ¼ 200)
Pain Case (n ¼ 103) JSL Case (n ¼ 103) Case (JSL and pain) (n ¼ 194)
Change in number of subregions
affected by any BML
1.1 (1.0,1.4) 0.1572 Ref 1.0 (0.8,1.3) 0.8961 1.4 (1.1,1.8) 0.0059 1.3 (1.0,1.6) 0.0375
Max change in BML score across
all subregions in knee
1.2 (1.0,1.4) 0.0122 Ref 0.9 (0.7,1.1) 0.3548 1.5 (1.2,1.9) 0.0013 1.3 (1.1,1.6) 0.0037
Change in number of medial
tibio-femoral subregions
affected by any BML
1.5 (1.1,1.8) 0.0023 Ref 0.9 (0.6,1.4) 0.7385 2.0 (1.4,2.8) 0.0002 1.8 (1.3,2.5) 0.0001
Max change in BML score in
medial tibio-femoral subregion
1.5 (1.3,1.8) <0.0001 Ref 1.0 (0.8,1.4) 0.7878 2.3 (1.8,2.9) <0.0001 2.0 (1.6,2.5) <0.0001
Change inter-condylar synovitis 2.2 (1.4,3.6) 0.0015 Ref 1.0 (0.5,2.2) 0.9106 1.7 (0.8,3.6) 0.1615 2.6 (1.4,4.7) 0.0018
Change in whole knee effusion 2.2 (1.6,2.8) <.0001 Ref 1.2 (0.8,1.8) 0.2946 1.5 (1.0,2.1) 0.0318 2.5 (1.8,3.5) <0.0001Imaging
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Purpose: Identiﬁcation of biomarkers associated with OA disease pro-
gression is of critical importance to advance the development of disease
modifying therapies. The objective of this study is to investigate if
change in semi-quantitative measures of joint morphology over 24
months is associated with clinically relevant progression in knee OA
over a 48-month follow-up period.
Methods: The FNIH OA Biomarkers Consortium undertook a nested case-
control study of progressive knee OA within the Osteoarthritis Initiative
(OAI). The case group (n ¼ 194) is deﬁned by the combination of knee
radiographic outcome (medial tibiofemoral joint space loss (mTF JSL)
0.7 mm) and symptom outcome (persistent worsening inWOMAC pain
score, reaching a minimum clinically important threshold of 9 points
(change from baseline) on a 0-100 normalised scale), each achieved for
the ﬁrst time at the 24, 36 or 48 month follow-up compared to baseline.
Main inclusion criteria were a Kellgren Lawrence grade (KLG) 1, 2 or 3 at
baseline from central reading and availability of knee radiograph and
magnetic resonance images (MRIs) at baseline and 24 months. Controls
(n ¼ 406) were knees eligible for the study that did not meet both
endpoint criteria, and consisted of: 200 super controls with noworsening
of either factor (pain or mTF JSL), 103 subjects with JSL but no pain
increase and 103with a persistent increase in pain but not JSL. KneeMRIs(not contrast enhanced) at baseline, 12 and 24 months were scored using
the MRI Osteoarthritis Knee Score grading systems for bone marrow
lesions (BMLs), intercondylar synovitis and effusion. BML, synovitis and
effusion score changes were categorized as improved, no change, wors-
ened within grade, worsened by one grade, or worsened by more than
one grade. Analyses were performed for change in the whole knee and,
for BMLs only, also for change in the medial tibio-femoral compartment.
Logistic regressionwas used to assess the risk of case status adjusting for
baseline age, sex, BMI, KLG and baseline pain.
Results: 194 cases of mean age 62 years, mean BMI 30.7 and 57% female
were compared to 406 controls of mean age 61 years, mean BMI 30.7 and
60% female. BML change from BL to 24 months was associated with case
status - particularly the maximum change in BML score in the medial
tibiofemoral compartmentOR 1.5 (95%CI 1.3,1.8) and change innumberof
subregions affected in the medial tibiofemoral compartment OR 1.5 (95%
CI 1.1,1.8) (Table). Change in effusion, OR 2.2 (95% CI 1.6,2.8), and synovitis,
OR 2.2 (95% CI 1.4,3.6), were both strong predictors of case status. There
were differential effects of BML change on the 3 types of case status (pain
case vs. JSL case vs. JSL and pain case, each compared to super controls)
with strong association with JSL cases as opposed to pain cases.
Conclusion: Change in semi-quantitative MRI features (BMLs, synovitis
and effusion) are potent predictors of clinical outcome. Intriguingly, the
prediction of clinical outcome from BMLs, synovitis and effusion
appears to be associated with stronger effects on structure.428
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Purpose: Quantitative MRI (qMRI) measures in knee osteoarthritis (OA)
capable of predicting key clinical endpoints such as total knee
replacement (TKR) have promise as prognostic biomarkers. Recently, it
was reported that very large BML volume (measured semi-quantita-
tively) in the medial tibiofemoral joint predicted a TKR 1 year later. We
now use a recently validated rapid qMRI software tool to examine
whether BML volume and change in volume predicts TKR 1 and 2 years
later. The purpose of this study was to examine the longitudinal rela-
tionship between BML volume and those who received a TKR, com-
pared with control knees with the same radiographic grade that did not
receive a TKR.
Materials and methods: A nested case-control study was conducted in
the Osteoarthritis Initiative (OAI), a multicenter cohort of 4796 partic-
ipants with or at risk for knee OA. Subjects who received TKR by the 48-
month visit who also had MRI scans (3T sagittal intermediate-weighted
turbo spin-echo fat-suppressed, 0.357  0.357  3.0 mm, TR 3200 ms,
TE 30 ms, intermediate-weighted) available for the 12 and 24 month
visit prior to the TKR were designated cases. Cases were matched 1:1
with subjects who did not receive TKR but were the same radiographic
disease grade (K–L grade score), same gender and age of the case.
Quantitative BML volumes in the tibia, femur and patella were
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knee replacement. Conditional logistic regression was applied to assess
the risk of TKR relative to the volume of BML size in each bone, the total
TFJ and PFJ and medial/lateral regions at 12 months and 24 months
prior to TKR We standardized the volumes by dividing them by the
standard deviation of the control group, allowing for direct comparison
between regions. The change in BML volume at these two prior visits
(and change between 24 and 12 month visits) was analyzed for case-
control pairs to determine the odds of future TKR.
Results: There were 278 subjects (138 cases, 138 controls) with 59%
female, an average age of 64.3 (SD  8.9) and BMI of 29.5 (SD  4.8).
Among cases, in the medial tibiofemoral joint, 42% had BML that
increased in size from 2 years to 1 year prior to TKR, 21% remained
unchanged and 37% decreased in size. Amongst controls, 39% increased
18% were unchanged and 43% decreased. The best region for dis-
tinguishing cases from controls was from total tibial BML volume. This
was true at 12 months prior to TKR (OR 1.68), at 24 months prior (OR
1.35), and from the change in volume from 24 to 12 moths prior (OR
1.23) (Table 1). At 12months prior toTKR, most regions of the femur and
tibia also showed differences in BML volume between cases and con-
trols (Table 1). At 24months prior toTKR, only the total tibia, total femur
(OR 1.28) and lateral tibiofemoral compartment (OR 1.28) were sig-
niﬁcant. We found no relationship between BML in the patellofemoral
joint and subsequent TKR at either timepoint or from change between
timepoints.
Conclusion: This study provides evidence that total BML volume in the
tibia is the best at distinguishing between cases and control, whether at
24 and 12 months prior to TKR or based on the BML volume change
from 24 to 12 months. Other regions of the tibia and femur were pre-
dictive as well, particularly 12 months before TKR. While the increased
odds are moderate, the controls were matched on radiographic grade
(K–L score) and the vast majority also had substantial BMLs. Further, a
substantial number of cases (37%) had BMLs that decreased in size from
24 to 12 months, a factor requiring further investigation. Lastly, TKR
while an important clincial endpoint has certain limitations that may
have attenuated our ﬁndings including access to care, patient/surgeon
preference, co-morbidities and disparities by race and socio-economic
status. Quantitative MRI measures of BML show promise as a predictive
biomarker for clinically meaningful outcomes. Future work on the
relationship between BML, pain and physical activity is under way.Table 1
BML volume by case – control status, odds from conditional GEE (only regions with signiﬁcant relationships are shown)
Knee region Cases mean Controls mean P-value Odds ratio 95% Lower CI 95% Upper CI
Fem medial 1.00 0.62 0.02 1.28 1.05 1.55
Fern total 1.14 0.70 0.03 1.34 1.02 1.77
12 mos. prior to TKR Tib lateral 1.11 0.35 0.00 1.45 1.17 1.80
Tib medial 1.26 0.69 <0.0001 1.48 1.21 1.79
Tib total 1.53 0.72 <0.0001 1.68 1.33 2.13
TibFem lateral 0.92 0.43 0.03 1.35 1.02 1.77
TibFem medial 1.21 0.70 0.00 1.46 1.18 1.80
Fem total 1.19 0.78 0.01 1.28 1.05 1.54
24 mos. prior to TKR Tib total 0.95 0.66 0.03 1.35 1.02 1.78
TibFem lateral 0.89 0.47 0.04 1.28 1.02 1.61
24 to 12 mos. change prior to TKR Tib lateral 0.31 0.05 0.03 1.22 1.02 1.46
Tib total 0.32 0.13 0.02 1.23 1.03 1.46429
VARIATIONS IN HIP SHAPE ARE ASSOCIATED WITH PREVALENT
RADIOGRAPHIC KNEE OA: THE JOHNSTON COUNTY
OSTEOARTHRITIS PROJECT
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Davis, Sacramento, CA, USAPurpose:We have previously identiﬁed associations between modes of
hip shape variation using active shape modeling (ASM) and incident
symptomatic radiographic hip OA. Given the biomechanical inter-
relationships between the hips and knees, and prior associations
between ipsilateral and contralateral joint OA at the hips and knees, we
sought to assess potential associations between hip shape modes and
prevalent radiographic knee OA.
Methods: Bilateral hips (n¼681, 3 hips were unsuitable for ASM)
were included from a prior study (at least one hip with Kellgren-
Lawrence grade [KLG] ¼ 0 or 1) for this cross-sectional analysis.
Proximal femur shape was deﬁned on baseline AP pelvis radiographs
and evaluated by ASM, producing a mean shape and continuous
variables representing independent modes of shape variation. Four-
teen mode scores, explaining 95% of shape variance, were simulta-
neously included in models, with prevalent radiographic knee OA
(KLG at the knee 2 or joint replacement) as the dependent varia-
ble. Limb-based logistic regression models for ipsilateral and con-
tralateral comparisons were adjusted for age, sex, race, BMI, and
radiographic hip OA, accounting for intra-person correlations. Based
on our prior work showing associations between modes 2 and 3
(Fig. 1) with incident symptomatic hip OA, we chose a priori to focus
on associations between knee OA and these modes, although all 14
modes were included in the model.
Results: We evaluated 681 hips and 682 knees from 342 individuals:
61.4% women, 82.5% white, mean age 61.7 years, and mean BMI 29.2
kg/m2. A total of 79 hips (12%) had prevalent radiographic OA at
baseline, while 95 knees had prevalent radiographic OA; only 4
knees had been replaced. Ipsilateral associations: we found a stat-
istically signiﬁcant association between a 1-standard deviation (SD)
decrease in hip mode 2 and prevalent ipsilateral knee OA on the
right only. A 1-SD decrease in hip mode 3 was associated with
having ipsilateral prevalent knee OA on both the right and the left
(Fig. 2, Table). Contralateral associations: a 1-SD decrease in mode 3
at the left hip was associated with knee OA on the right, but not
vice versa (Fig. 2, Table). Other hip modes were not consistently
associated with knee OA.
Conclusions: Variations in the shape of the hip were related to the
presence of radiographic knee OA at baseline in this cohort, although
the relationships vary among ipsilateral and contralateral joint
pairings. These variations may reﬂect biomechanical differencesbetween limbs, such as dominant vs. non-dominant limbs or limb
length inequality. Although we cannot determine causality from this
cross-sectional work, hip joint shape may lead to altered knee joint
mechanics and a greater risk of OA, or knee OA could impact
remodeling at the hip, or a combination of these. Future analyses
will assess longitudinal relationships between hip shape and OA risk
at other joints and explore factors associated with ipsilateral and
contralateral relationships.
